Our results show that although the detection of CRFR1 and CRFR2 methylation in ccfDNA does not hold a diagnostic value, methylation levels considered in the context of an ML-built biosignature can help in differentiating healthy individuals from CRC patients. The gene discussed is CRHR1; the disease is colorectal carcinoma.